AR122929A1 - Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de enfermedades - Google Patents
Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de enfermedadesInfo
- Publication number
- AR122929A1 AR122929A1 ARP210101931A ARP210101931A AR122929A1 AR 122929 A1 AR122929 A1 AR 122929A1 AR P210101931 A ARP210101931 A AR P210101931A AR P210101931 A ARP210101931 A AR P210101931A AR 122929 A1 AR122929 A1 AR 122929A1
- Authority
- AR
- Argentina
- Prior art keywords
- diseases
- treatment
- pharmaceutical compositions
- new compounds
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2010464.2A GB202010464D0 (en) | 2020-07-08 | 2020-07-08 | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR122929A1 true AR122929A1 (es) | 2022-10-19 |
Family
ID=72050551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210101931A AR122929A1 (es) | 2020-07-08 | 2021-07-08 | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de enfermedades |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR122929A1 (fr) |
| GB (1) | GB202010464D0 (fr) |
| TW (1) | TW202216678A (fr) |
| WO (1) | WO2022008383A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022128850A1 (fr) * | 2020-12-16 | 2022-06-23 | Galapagos Nv | Nouveaux dérivés d'isoquinoline et compositions pharmaceutiques associées pour le traitement de maladies |
| JP2024513227A (ja) | 2021-04-05 | 2024-03-22 | ハリア・セラピューティクス・インコーポレイテッド | Ｎｅｋ７阻害剤 |
| WO2022226182A1 (fr) | 2021-04-22 | 2022-10-27 | Halia Therapeutics, Inc. | Inhibiteurs de nek7 |
| US20240158394A1 (en) | 2022-09-14 | 2024-05-16 | Halia Therapeutics, Inc. | Nek7 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104105691A (zh) * | 2011-11-08 | 2014-10-15 | 艾尼纳制药公司 | G蛋白偶联mas受体调节剂及对与其相关的病症的治疗 |
| JP2018502900A (ja) * | 2014-10-22 | 2018-02-01 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | ジスコイジンドメイン受容体１を標的化する小分子阻害剤およびその使用 |
-
2020
- 2020-07-08 GB GBGB2010464.2A patent/GB202010464D0/en not_active Ceased
-
2021
- 2021-07-02 WO PCT/EP2021/068377 patent/WO2022008383A1/fr active Application Filing
- 2021-07-07 TW TW110124900A patent/TW202216678A/zh unknown
- 2021-07-08 AR ARP210101931A patent/AR122929A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202216678A (zh) | 2022-05-01 |
| WO2022008383A1 (fr) | 2022-01-13 |
| GB202010464D0 (en) | 2020-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR122929A1 (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de enfermedades | |
| CO2020000056A2 (es) | Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de la fibrosis | |
| CL2022001739A1 (es) | Compuestos tricíclicos sustituidos | |
| AR124916A2 (es) | Piridinas sustituidas con heteroarilo y métodos de uso | |
| ECSP21030066A (es) | 2-amino-n-heteroaril-nicotinamidas como inhibidores de nav1.8 | |
| NI201800093A (es) | Inhibidores de mcl1 macrocíclicos para tratar el cáncer | |
| CL2021000737A1 (es) | Fabricación de compuestos y composiciones para inhibir la actividad de shp2 | |
| CO2018009876A2 (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de fibrosis | |
| CO2022008997A2 (es) | Compuestos tricíclicos sustituidos | |
| UY39646A (es) | Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| UY37774A (es) | Compuestos 5-cianoindol sustituidos y usos de los mismos | |
| BR112021024131A2 (pt) | Derivado de anel inibidor de btk, método de preparação para o mesmo e aplicação farmacêutica do mesmo | |
| BR112015020998A2 (pt) | compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios | |
| EA201692176A1 (ru) | Полифторзамещенное соединение в качестве ингибитора тирозинкиназы брутона (btk) | |
| DOP2017000139A (es) | Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de desórdenes inflamatorios y oesteoartritis | |
| CU20130040A7 (es) | DERIVADOS DE PIRAZINA COMO BLOQUEADORES DE ENaC | |
| PH12018501434A1 (en) | Cyclic amine derivative and medical use thereof | |
| CO2020005200A2 (es) | Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios | |
| CO2020001346A2 (es) | Pirrolopirimidina y derivados de pirrolopirimidina | |
| CO2021000159A2 (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de enfermedades | |
| CO2021014223A2 (es) | Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de trastornos inflamatorios | |
| CL2020001047A1 (es) | Derivados de imidazol condensado sustituidos por grupos de hidroxia terciaria como inhibidores pi3k-gamma. | |
| CL2021001656A1 (es) | Compuestos de imidazopiridina e imidazopiridina y sus usos. | |
| CL2022001741A1 (es) | Compuestos cíclicos y métodos de uso de estos | |
| CU20200067A7 (es) | Derivados de imidazolidin-2-ona sustituidos como inhibidores de prmt5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |